$99.45
+9.02 (+9.97%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+22.29%
1Y
+114.84%
YTD
+36.68%
Open$92.84
Previous Close$90.43
Day High$105.00
Day Low$91.74
52W High$103.00
52W Low$36.65
Volume—
Avg Volume717.4K
Market Cap7.44B
P/E Ratio—
EPS$-3.57
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.66
Above
SMA 200
$56.03
Above
RSI (14)
77.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
30 analysts
Price Target
-68.8% upside
Current
$99.45
$99.45
Target
$31.03
$31.03
$20.33
$31.03 avg
$33.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.18M | 40.50M | 7.83B |
| Net Income | -303,119,183 | -289,450,678 | 335.40M |
| Profit Margin | -794.0% | -754.3% | 4.3% |
| EBITDA | -332,073,852 | -334,716,349 | 592.59M |
| Free Cash Flow | — | — | 369.62M |
| Rev Growth | -5.8% | -5.8% | +18.7% |
| Debt/Equity | 0.00 | 0.00 | 0.53 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |